Eladocagene Exuparvovec
PTC-AADC-GT-002
Phase 2 gene_therapy active
Quick answer
Eladocagene Exuparvovec for AADC Deficiency is a Phase 2 program (gene_therapy) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- AADC Deficiency
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active